Electronic Cigarettes clinical trials at UCSF
3 research studies open to eligible people
Cigarette Harm Reduction With Electronic Cigarette Use
open to eligible people ages 21-70
This is an observational, crossover study that will be examine use behaviors, chemical exposures, and biological effects of SREC compared to TC use in subjects confined to a research ward setting.
San Francisco, California
Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes
open to eligible people ages 21-70
This is an observational, crossover design that will examine the pharmacokinetics and pharmacodynamics of impact of smoking tobacco cigarettes or vaping the JUUL electronic cigarette.
San Francisco, California and other locations
Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH
open to eligible people ages 21-70
This study will examine the short-term cardiovascular (CV) effects of e-liquid pH in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim of the study is to assess the impact of changes in e-liquid pH on nicotine pharmacokinetics, cardiovascular, and subjective effects of e-cigarettes.
San Francisco, California and other locations
Our lead scientists for Electronic Cigarettes research studies include Gideon St.Helen Neal Benowitz.
Last updated: